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Abstract.  Phosphorylation of the regulatory light 
chain of myosin II (MLC) controls the contractility of 
actomyosin in nonmuscle and muscle cells.  It has been 
reported that cdc2 phosphorylates MLC in vitro at 
Ser-1  or Ser-2 and Thr-9  which protein kinase C 
phosphorylates (Satterwhite,  L.  L.,  M. J.  Lohka, 
K. L.  Wilson,  T.  Y.  Scherson,  L.  K.  Cisek, J.  L. 
Corden,  and T.  D.  Pollard.  1992. J.  Cell Biol. 
118:595-605).  We have examined in vivo phosphory- 
lation of MLC during mitosis and after the release of 
mitotic arrest.  Phosphate incorporation of MLC in mi- 
totic cells is found to be 6-12 times greater than that 
in nonmitotic cells. Phosphopeptide maps have re- 
vealed that the MLC from mitotic cells is phos- 
phorylated at Ser-1  and/or Set-2 (Ser-1/2),  but not at 
Thr-9.  MLC is also phosphorylated to a much lesser 
extent at Ser-19 which myosin light chain kinase phos- 
phorylates.  On the other hand,  MLC of nonmitotic 
cells is phosphorylated at Ser-19  but not at Ser-l/2. 
The extent of phosphate incorporation  is doubled at 30 
min after the release of mitotic arrest when some cells 
start cytokinesis. Phosphopeptide analyses have re- 
vealed that the phosphorylation at Ser-19 is increased 
20 times, while the phosphorylation at Ser-1/2  is de- 
creased by half.  This high extent of MLC phosphory- 
lation at Ser-19 is maintained  for another 30 min and 
gradually decreased to near the level of interphase 
cells as cells complete spreading at  180 min.  On the 
other hand,  phosphorylation at Set-l/2 is decreased to 
18%  at 60 min,  and is practically undetectable at  180 
min after the release of mitotic arrest.  The stoichiom- 
etry of MLC phosphorylation has been determined by 
quantitation of phosphorylated and unphosphorylated 
forms of MLC separated on 2D gels.  The molar ratio 
of phosphorylated MLC to total MLC is found to be 
0.16  +  0.06 and 0.31  5:0.05  in interphase and mi- 
totic cells, respectively. The ratio is increased to 0.49 
+  0.05  at 30 min after the release of mitotic arrest. 
These results suggest that the change in the phos- 
phorylation site from Ser-1/2  to Ser-19 plays an impor- 
tant role in signaling cytokinesis. 
T 
HE microfilament  cytoskeleton of cultured cells un- 
dergoes massive reorganization  during  mitosis  (29, 
32). Microfilament  bundles or stress fibers are disas- 
sembled into a dispersed state during prophase concomitant 
with cell rounding.  Subsequently,  a contractile ring is tran- 
siently formed between two poles. After chromosome segre- 
gation, the contractile ring is activated to separate the cyto- 
plasm into two daughter cells. Stress fibers are re-assembled 
as cells start to spread.  The molecular mechanisms  underly- 
ing these changes  in microfilament  organization,  however, 
are largely  unknown (for review see references  11 and 24). 
In particular,  what controls the formation  and activation of 
the contractile rings has been a primary objective for investi- 
gation. 
Myosin II is accumulated in the contractile  rings (11, 30), 
and known to function as the motor for the cytokinesis (8, 
20, 25). It is thus quite reasonable to assume that the system 
controlling cytokinesis should involve the regulation of myo- 
sin II activity in contractile rings. Recently, Satterwhite et al. 
(31) have made a very interesting discovery: that the regula- 
tory light chain  of myosin II (MLC)t is phosphorylated in 
vitro by cdc2 kinase at the sites which protein kinase C phos- 
phorylates (Ser-1 or Ser-2 and Thr-9;  C-kinase  sites).  The 
phosphorylation of MLC at the C-kinase sites is known to 
inhibit  actin-activated  myosin II ATPase and to reduce the 
stability of myosin II filaments  (2,  15, 28). As the activity 
of cdc2 kinase drops abruptly during  metaphase/anaphase 
transition,  they have proposed an attractive  model, namely 
that the phosphorylation of MLC at the C-ldnase sites keeps 
myosin II from activating  until the onset of anaphase.  The 
dephosphorylation of MLC at the C-kinase sites caused by 
the drop in the cdc2 activity would thus be a signal to activate 
contractile  rings during  the anaphase/telophase  transition. 
In vivo phosphorylation of MLC during  mitosis has not 
been determined to verify this hypothesis.  Using a cultured 
1. Abbreviations used in this paper: MLC, light chain of myosin II; 2D, two 
dimensional. 
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cells is indeed phosphorylated mainly at Ser-1/2.  Although 
protein kinase C phosphorylates Thr-9 in addition to Ser-1/2, 
phosphorylation at Thr-9 has not been observed in vivo. On 
the other hand, MLC of interphase cells is primarily phos- 
phorylated at Ser-19 which MLCK phosphorylates (MLCK 
site). After the release of mitotic arrest, the phosphorylation 
at  Ser-1/2  is  decreased  while the  phosphorylation at  the 
MLCK site is greatly increased as cells go into cytokinesis 
followed by cell spreading.  These results suggest that the 
changes in the MLC phosphorylation sites may be a signal 
to activate contractile rings during cell division. 
We have also examined in vitro phosphorylation of MLC 
by cdc2 kinase purified from mitotic HeLa cells. We have 
confirmed the previous results by Satterwhite et al., (31) that 
cdc2 kinase phosphorylates MLC in vitro at the C-kinase 
sites (Ser-1/2 and Thr-9). However,  our cdc2 kinase shows 
a much lower MLC-kinase activity than does protein kinase 
C, suggesting that additional factors or other kinase(s) may 
be involved in the mitosis-specific phosphorylation of MLC. 
Materials and Methods 
Cell Culture and Preparation of  Mitotic Cells 
SV-40 transformed rat embryo (REF-4A) and HeLa cells were used in the 
present study.  Both cells were maintained in Dulbecco's modified Eagle's 
medium (DME)  containing  10%  newborn calf serum (NCS)  in  an at- 
mosphere of 5% CO2 and 95%  air at 37°C. 
REF4A cells at metaphase and later stages during cell division were pre- 
pared as described previously (13, 38, 39). Briefly,  cells were first treated 
for 3 h with 0.25 t~g/ml nocodazole, and mitotic cells were collected as de- 
scribed previously (38). After washed with DME at 0°C to remove nocoda- 
zole, cells were plated in fresh culture dishes, and incubated at 37°C in 
DME containing 10% newborn calf serum to allow cell cycle progression. 
Cell morphologies were checked by phase-contrast light microscopy as de- 
scribed previously (13). 
Proteins 
Smooth muscle and nonmuscle myosin II were prepared from chick gizzard 
and bovine adrenal medulla, respectively, as described (34). Myosin light 
chain was a generous gift from Dr. J. Sellers. Myosin light chain kinase was 
prepared from chick gizzard as described (1). Protein klnase C and Histone 
H1  were purchased from Lipidex and Boehringer, respectively, p13  was 
purified from pl3-expressing bacterial strain, pRK172  sucl, (kindly pro- 
vided by Dr. E  Nurse) as described (5) and conjugated to Sepharese 4B 
according to the manufacturer's instructions (Pharmacia Fine Chemicals, 
Piscataway,  NJ). 
In Vivo  Phosphorylation of  Myosin Light Chain 
during Cell Division 
REF-4A cells at mitosis or later stages were labeled with [32p] orthophos- 
phoric acid as described previously (13, 38, 39). Briefly,  cells were incu- 
bated for 3 h in phosphate-free  DME containing 10% dialyzed newborn calf 
serum, 0.25/~g/ml nocodazole, and 0.125  mCi/ml [32p] orthophosphoric 
acid. Mitotic and nonmitotic cells were then collected as described (38). 
In some experiments, cells were continuously labeled with [32p] ortho- 
phosphoric acid after the release of mitotic arrest in the manner described 
below. Mitotic ceils were washed quickly with phosphate-free DME at 0*C 
to remove nocodazole, and incubated at 37°C in phosphate-free DME con- 
taming the same radioactivity of 32p. Cells at different stages of mitosis 
were lysed in immunoprecipitation buffer containing 25 mM Tris-HCl, pH 
8.0, 100 mM NaF, 250 mM NaC1,  10 mM EGTA, 5 mM EDTA, 100 mM 
NazP2OT,  1 mM PMSF, and 1%  NP-40, and stored in a  -80°C freezer. 
After being thawed quickly, the lysates were homogenized by several pas- 
sages through a 25-gauge needle, and centrifuged in an Eppendorf centri- 
fuge for 30 rain. The supernatants were immediately used for immunopre- 
cipitation using anti-myosin II heavy chain polyclonal antibody (kindly 
provided by Dr. J. Sellers, NIH, Bethesda, MD). The immunoprecipitates 
were then analyzed on an SDS gel, followed by autoradiography. As myosin 
heavy chain bands in the immunoprecipitates were visible on Coomassie 
blue-stained gels, their intensities determined by densitometry were used 
for normalization of the amounts of myosin. 
The stoichiometry of the phosphorylation has been determined by den- 
sitometry of two-dimensional (2D)  gels which separate phosphorylated 
forms of MLC from unphosphorylated MLC (19, 23).  REF4A cells were 
labeled for 3.5 h with 40 #Ci/ml of TRAN33S-LABEL (ICN, Irvine, CA) 
in methionine-free DME or 2.5/~Ci of 14C-leucine in leucine-free DME, 
followed by 2.5 h of incubation in the presence of nocodazole. Mitotic, non- 
mitotic cells and cells at 30 rain after the release of mitotic arrest were col- 
lected as described above. Myosin immunoprecipitated from these cells was 
analyzed on 2D gels using Investigator 2-D electrophoresis system from 
Millipore (Millipore Corp., Bedford, MA). The radioactivities of phos- 
phorylated and unphosphorylated forms of MLC were quantitated using a 
Phosphorlmager (Molecular Dynamics Inc., Sunnyvale, CA). 
Phosphopeptide Mapping and Phosphoamino 
Acid Analyses 
MLC bands labeled with 32p either in vivo or in vitro were excised from 
SDS  gels.  Tryptic  phosphopeptides were  prepared  with  TPCK-trypsin 
(Worthington Biochem. Corp., Freehold, NJ) and mapped by one dimen- 
sional isoelectric focusing as described (27). Briefly, gel slices were washed 
with 25% 2-isopropyl alcohol three times, 10% methanol three times, and 
dried completely. After addition of 950 #1 of 100 mM NI-I4HCO2 and 50 
~tl of 1 mg/ml of TPCK-trypsin to dried gel slices, the samples were shaken 
for 16-24 h at 37°C. Another 50 #1 of trypsin was added halfway through 
digestion. Trypsin digests were analyzed on isoelectric focusing gels con- 
taining 7.0 % acrylamide, 0.22 % bisacrylamide, ampholytes (pH 2.5/4, pH 
3.5/5 and pH 5/8, each at 0.8%) and 6 M urea. Focusing was run at 25 watts 
for 60 min with 0.1 M NaOH as cathode buffer and 0.1 M H3PO4 as anode 
buffer. 
Phosphoaminoacids of each of the phosphopeptides separated on one- 
dimensional isoelectric focusing gels were determined in the following way: 
because 6 M urea disturbed phosphoamino acid analyses, phosphopeptides 
of MLC were first separated on silica gels by the method of 2D mapping 
(18).  The  phosphopeptides thus  separated  were  eluted  with  water  and 
divided into two aliquots.  One half of the eluent was analyzed by one- 
dimensional isoelectric focusing as described above, and the other half was 
used  for the phosphoaminoacid analyses (14).  For  acid hydrolysis, the 
lyophilized samples were directly dissolved in 6 M HC1 and hydrolyzed for 
2 h at 110°.C. After removing HCI under reduced pressure, the hydrolysates 
were  dis~gJved  in  a  marker  mixture  containing  phosphoserine,  phos- 
phothreonine, and phosphotyrosine, each at  1 mg/mi. Acid hydrolysates 
were analyzed on cellulose thin-layer plates (Kodak chromatogram sheet, 
13255 cellulose) (Eastman Kodak Co., Rochester, NY) by electrophoresis 
at pH 3.5 for 1 h at 1 kV in glacial acetic acid:pyridine:H20 =  50:5:945 
(vol/vol). The phosphoaminoacid markers were detected by staining with 
ninhydrin. 
Fractionation of  MLC Kinase and cdc2 Kinase 
To prepare MLC kinase and cdc2 kinase from mitotic cells, HeLa cells were 
grown to subconfluency on 56 large culture dishes (245  x  245 ram, Nunc) 
in DME containing 6% calf serum, and were treated with 0.25 #g/ml of 
nocodazole for 16 h.  Mitotic cells were collected and treated with Tri- 
ton/glycerol solution (0.1 M Pipes-NaOH, 5 mM MgC12, 0.2 mM EGTA, 
4 M glycerol and 0.05%  Triton X-100, pH 6.9), and homogenized with an 
equal volume of phosphate-buffered saline (137 mM NaC1, 2.7 mM KCI, 
1.5 mM KH2PO4,  8 mM Na2HPO4,  pH 7.3) containing 0.2 mM EGTA, 5 
mM MgCI2,  1 mM PMSF, and 1 mM DTT. The superuatants obtained af- 
ter centrifugation at 200,000 g  for  1 h,  were fractionated by Sephacryl 
S-300 gel filtration. Both MLC and histone H1 were used as substrates to 
detect MLC and histone H1 ldnase activities. Nonmitotic cells after collec- 
tion of mitotic cells were fractionated in the same way. For the purification 
of cdc2 kinase, Sephacryl S-300 fractions with a peak histone H1 kinase 
activity were further fractionated by p13 affinity column chromatography 
as described (21). After loading, the p13 column was sequentially washed 
with the following three solutions; solution A (20 mM imidazole buffer of 
pH 7.0, 1 mM DTT, 2 mM MgC12, 1 mM EGTA, 0.25 mM PMSF); solu- 
tion A containing 0.5 M NaC1, solution A containing 50% ethylene glycol. 
cdc2 ldnase was then eluted with solution A containing both 0.5 M NaC1 
and 50% ethylene glycol. The concentrated, purified cdc2 kinase was found 
to phosphorylate histone H1 at a rate of 16-17 pmol/min/#l. In some experi- 
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scribed (5). 
The assay conditions for MLC and histone H1 kinase are as follows: ei- 
ther purified MLC (30/~g/ml) or histone H1  (10 ~g/ml) in 20 ttl of PBS 
was mixed ~vith column fractions in the presence of 5 mM MgCI2, 0.2 mM 
EGTA,  500  nM  A-kinase inhibitor peptide (Sigma  Chemical  Co.,  St. 
Louis, MO), 0.125 mCi/ml of [~-32p]ATP and 0.1 mM ATP. The mixtures 
were incubated at room temperature for20 min. The reactions were stopped 
by addition of 2x  SDS sample buffer,  and the samples were subjected to 
SDS-PAGE followed by autoradiography. In some experiments, MLC and 
histone H1 bands were excised from the gel and the radioactivities of those 
bands were counted by a scintillation counter using the Cerenkov method. 
The conditions for the phosphorylation of MLC by MLCK are as fol- 
lows: 20 mM imidazole, pH 7.0, 0.1 M KCI, 0.5 mM CaC12, 5 mM MgCI2, 
0.5 mM ATP, 4 #g/ml calmodulin, 16 tzg/ml MLCK, 1 mM DTT, 500 nM 
A-kinase inhibitor. The reaction mixtures for the phosphorylation of MLC 
by protein kinase C  include 20 mM imidazole buffer,  pH 7.0, 0.1  M KCI, 
0.5 mM CaCI2, 5 mM MgCI2, 0.5 mM ATP, 1 mM DTT, 500 nM A-kinase 
inhibitor, 200 ~g/ml phosphatidylserine, 9 ttg/ml of protein kinase C. 
Other Procedures 
SDS-PAGE was performed as described by Blatter et al.  (3) using 12.5% 
polyacrylamide except that the buffer system  of  Laemmli (22) was used. The 
intensities of each protein band on SDS gels and autoradiographs were ana- 
lyzed with a densitometer (Chromoscan 3, Joyce-l.,oebl)  as described (17). 
Protein concentrations were determined by the method of  Bradford (4) using 
bovine serum albumin as a standard. 
Results 
In Vivo Phosphorylation of  MLC during Mitosis 
We have first examined whether MLC is phosphorylated in 
a mitosis-specific way. Mitotic and nonmitotic REF-4A cells 
were labeled in vivo with 32P-orthophosphate  for 3 h in the 
presence of nocodazole, and mitotic cells were collected as 
described in the section of Materials and Methods. Both my- 
osin heavy and light chains were immunoprecipitated as a 
complex from total cell lysates of mitotic and nonmitotic 
cells using an anti-heavy chain antibody (kindly provided by 
Dr. J. Sellers). As Fig.  1 A shows, MLC is phosphorylated 
to a much greater extent in mitotic cells than in nonmitotic 
cells.  Quantitative analyses using  scintillation counting or 
densitometry of autoradiographs have shown that MLC in 
mitotic cells is 6-12 times more phosphorylated than is MLC 
in nonmitotic cells. When the SDS gel is lightly exposed, the 
myosin heavy chains are found to be phosphorylated in both 
mitotic and nonmitotic cells. However, unlike phosphoryla- 
tion of MLC, the extent of heavy chain phosphorylation is 
indistinguishable between mitotic and nonmitotic cells. 
Analyses of  Phosphorylation Sites During Mitosis 
The sites of in vivo phosphorylation have been analyzed by 
one-dimensional phosphopeptide mapping. For comparison, 
MLC of smooth muscle myosin II was phosphorylated in 
vitro by either MLCK or protein kinase C, and the phos- 
phorylated MLC bands were analyzed in the same way. 
The phosphopeptide pattern of  mitotic MLC is similar, but 
not identical, to that of MLC phosphorylated by protein ki- 
nase C. As Fig. 1 B shows, the phosphopeptide pattern of mi- 
totic MLC yields two major and one minor spots. Of these, 
the two major spots comigrate with the phosphopeptide spots 
generated by the phosphorylation of MLC with protein ki- 
nase C. The minor spot, on the other hand, corresponds with 
the  spot produced  by  the  phosphorylation of MLC  with 
MLCK.  Phosphoaminoacid analyses have revealed that all 
Figure L Mitosis-specific phosphorylation of MLC (.4) and analy- 
ses of the phosphorylation sites (B). (A) Autoradiography of SDS 
gels to analyze in vivo phosphorylation of regulatory MLC in mi- 
totic and nonmitotic REF-4A cells. Mitotic and nonmitotic cells 
were labeled in vivo with 32p-orthophosphate, and myosin II was 
immunoprecipitated from total cell lysates using anti-heavy chain 
antibody. MLC from mitotic cells is phosphorylated 6-12 times 
higher than MLC from nonmitotic cells. Lane 1, myosin immuno- 
precipitated from mitotic cells; lane 2, myosin immunoprecipitated 
from nonmitotic cells. The positions of heavy chain (MHC) and 
regulatory light chain (MLC) are indicated. M,  mitotic cells; I, 
nonmitotic  cells.  (B)  Phosphopeptide  analyses. In  vivo  phos- 
phorylated MLC was digested with trypsin, and analyzed by one- 
dimensional phosphopeptide mapping using isoelectric focusing 
gel electrophoresis. For comparison, MLC phosphorylated in vitro 
either by protein kinase C or by MLCK was also analyzed. MLC 
from mitotic cells is mainly phosphorylated at Ser-1 and/or Ser-2 
sites but not at Thr-9. MLC from interphase cells is phosphorylated 
at Ser-19. Lane 1, in vitro phosphorylation by protein kinase C; lane 
2, in vivo phosphorylation in mitotic cells; lane 3, in vivo phos- 
phorylation in nonmitotic cells; lane 4, in vitro phosphorylation by 
MLCK. PKC, protein kinase C; M, mitotic cells; I,  nonmitotic 
cells; MLCK, myosin light chain kinase. An arrowhead with aster- 
isk shows a minor phosphopeptide band generated by phosphoryla- 
tion  with  MLCK.  Phosphoaminoacid  analyses  failed  to  show 
whether  it comes  from phosphorylation at  Ser-19 or Thr-18 of 
MLC. 
mitotic spots contain phosphoserine (data not shown), indi- 
cating that mitotic MLC is mainly phosphorylated in vivo at 
Ser-1  and/or Ser-2 while it is also phosphorylated, though 
to a much lesser extent, at Ser-19. 
On the contrary, little phosphorylation at Ser-1/2  is ob- 
served with nonmitotic MLC.  Instead,  phosphorylation at 
Ser-19 is recognizable to the extent similar to that observed 
with mitotic MLC. Several minor phosphopeptide bands are 
also  recognized with  nonmitotic MLC.  These bands  may 
come from phosphoproteins contaminated in the preparation 
of nonmitotic MLC because a large amount of nonmitotic 
MLC had to be loaded, due to the low radioactivity of non- 
mitotic MLC. 
Mitotic MLC lacks two phosphopeptide spots which are 
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kinase C.  Phosphoamino acid analyses have revealed that 
one spot close to the origin contains phosphothreonine and 
the other spot contains phosphoserine (data not shown). This 
suggests that mitotic phosphorylation does not occur at Thr-9 
in contrast to the phosphorylation by protein kinase C. The 
inclusion of phosphatase inhibitors such as NaF during im- 
munoprecipitation did not change the phosphopeptide pat- 
terns of  mitotic MLC, suggesting that the absence of the Thr-9 
spot is not due to contaminating phosphatase activities. 
Changes in the Sites and Extents of Phosphorylation 
After the Release of  Mitotic Arrest 
The above results demonstrate that MLC is phosphorylated 
in vivo at Set-1 and/or Ser-2 during prometaphase. Cytoki- 
nesis involves activation of myosin II, therefore it is of in- 
terest to determine whether the phosphorylation states of 
MLC  change during cell division.  Mitotic cells were al- 
lowed to proceed through division following the removal of 
nocodazole from media. Myosin II was immunoprecipitated 
at various times after the release of mitotic arrest, and the 
extents of MLC phosphorylation were quantitated by den- 
sitometry. At the same time cell morphology was checked by 
light microscopy as reported previously (13). 
The total level of MLC phosphorylation is increased as 
cells are allowed to divide, and decreased when cells finish 
spreading (shown by open bars in Fig. 2). At 10 min after 
the release of mitotic arrest, virtually no cells are dividing 
and the total level of MLC phosphorylation is unchanged. 
At 30 min when <•0%  of the cells exhibit the early stages 
of cytokinesis, the total level of  phosphorylation is increased 
by more than twofold. By 60 rain >60% of  the cells complete 
division, and the level of MLC phosphorylation is slightly 
lowered by 18%. At 180 rain when cells complete spreading 
and assembly of stress fibers, the total level of phosphoryla- 
tion is decreased to 23 % of the level at 30 rain. 
Phosphopeptide analyses have been performed to eluci- 
date whether the  sites of phosphorylation are changed as 
cells undergo cell division. Fig.  3 shows the peptide maps 
of MLC at 30 and 60 min after the release of mitotic arrest. 
The phosphorylation at Ser-1/2 is decreased as cells are in- 
cubated  longer,  while  the  phosphorylation  at  Ser-19  is 
greatly increased (compare Fig. 3, lanes 1 and 2 with Fig. 
1 B, lane 2). 
In  addition  to  the  phosphorylation  at  Ser-19,  a  band 
(shown by an arrowhead with asterisk) becomes recogniza- 
ble with the maps obtained at 30 min and 60 rain. As the 
band  co-migrates  with  the  minor  band  generated by the 
phosphorylation of MLC by MLCK (see Fig.  1 B, lane 4) 
this minor band, together with the major band correspond- 
ing to Ser-19, are assigned as the MLCK sites. This spot may 
be the di-phosphorylated Ser-19/Thr-18, which is known to 
be phosphorylated by MLCK. 
We have analyzed the changes in the levels of  phosphoryla- 
tion at each site by densitometry of the phosphopeptide maps 
obtained at 0,  10, 30,  60, and 180 min (Fig. 2). At 10 min 
when the total phosphorylation level (open bars in Fig. 2) 
is not altered, the phosphorylation at Ser-1/2 (cross-hatched 
bars) is decreased by half whereas the phosphorylation at the 
MLCK sites gilled bars) is increased six times. At 30 min 
the phosphorylation at the MLCK sites is increased greatly, 
becoming  a  major  site  while  phosphorylation  at  Ser-1/2 
'~  20 
~o 
a. 
•  MLCK sites 
[]  Set 1/2  | 
!  []  total 
I  M  10  rflln  30  rain  60  rain  180  rain 
Figure 2. Changes in levels and sites ofMLC phosphorylation after 
release of mitotic arrest. Myosin H was immtmopreeipitated from 
REF-4A cells at 10, 30, 60, and 180 rain after the release of mitotic 
arrest. Myosin H was also immunoprecipitated from nonmitotic (I) 
and mitotically arrested cells (M). Immunoprecipitates were ana- 
lyzed by SDS-PAGE, and the total levels of MLC phosphorylation 
(D) at these different incubation times were determined by den- 
sitometry  of autoradiography  of gels. Phosphopeptide analyses 
were also performed at the same time (see Fig. 3), and the extents 
of phosphorylation at either Ser-1/2 (El) or at the MLCK sites (I) 
were  again determined  by densitometry  of the  phosphopeptide 
maps. The levels ofphosphorylation are expressed in arbitrary units 
by making the total level of MLC phosphorylation in nonmitotic 
cells equal to one. 
seems to be decreased slightly At 60 min, the level of phos- 
phorylation at the MLCK sites is still high while phosphory- 
lation at Ser-1/2 is greatly reduced to 18% of the level found 
in mitotic MLC. At 180 min, the level of phosphorylation 
Figure 3.  Phosphopeptide maps  of 
cells at 30 and 60 rain after the re- 
lease of mitotic arrest.  Lane 1, 30 
min after the release of mitotic ar- 
rest; lane 2, 60 min after the release 
of  mitotic arrest. Note that the extent 
of phosphorylation at Ser-1/2 is de- 
creased while the phosphorylation at 
Ser-19 is greatly increased. As an ad- 
ditional phosphopeptide band  indi- 
cated by an arrowhead with asterisk 
co-migrates with the phosphopeptide 
generated by phosphorylation  with 
MLCK (see Fig. 1 B), the band is as- 
signed as a MLCK site. 
The Journal of Cell Biology,  Volume 124, 1994  132 Figure 4. 2D gel analyses of MLCK from nonmitotic cells (A and B), mitotically arrested cells (C and D), and cells 30 min after the 
release of mitotic arrest (E and F). REF-4A cells were labeled with either a mixture of [35S]methionine  or [35S]cysteine  (A, C, and E) 
or 32p-orthophosphate (B, D, and F) as described in Materials and Methods, and immunoprecipitated myosin II were analyzed by 2D gel 
electrophoresis. Only parts of 2D gels including regulatory and essential light chains are shown. Approximately equal amounts of myosin 
II were loaded. 
at the MLCK sites is decreased to 25 % of  the level at 30 min, 
whereas the phosphorylation at Ser-1/2 becomes almost un- 
detectable.  These  results  suggest  that  switching  of phos- 
phorylation sites from Ser-1/2  to the MLCK sites seems to 
occur during cell division. 
Stoichiometry of  MLC Phosphorylation during Mitosis 
To examine whether the increase in phosphate incorporation 
during  mitosis  and  subsequent  cell  division  reflects  real 
changes in the phosphorylation states of MLC, we have de- 
termined the molar ratio of phosphorylated forms to the un- 
phosphorylated form of MLC. Myosin II was immunopre- 
cipitated  from cells  that  had  been  labeled  with  either  a 
35S-methionine/cysteine mixture  or  ~4C-leucine.  Then  un- 
phosphorylated and  phosphorylated forms  of MLC  were 
separated on 2D gels. Similar results were obtained with ei- 
ther 35S- or t4C-labeled  cells. 
First,  we  have  identified  unphosphorylated  and  phos- 
phorylated forms of rat cell MLC on 2D gels. Fig. 4A shows 
the part of  the 2D gel which includes both regulatory and es- 
sential light chains of 35S-labded nonmitotic cells. Fig. 4 B 
shows the corresponding part of the 2D gel with 32P-labeled 
nonmitotic  myosin.  Spots  a  and  b  are  assigned  as  un- 
phosphorylated and phosphorylated forms of MLC, respec- 
tively, because only spot b is labeled with 32p-phosphate as 
shown in Fig. 4 B. A  spot c in Fig. B is likely to be a di- 
phosphorylated form of MLC, the level of which is too low 
in nonmitotic cells to be detected by 35S-labeling. 
The identifications of the spots a and b were confirmed by 
the following two ways:  First,  myosin II partially purified 
from cultured rat cells was phosphorylated in vitro either 
with MLCK or PKC, and 2D gel patterns of MLC were ana- 
lyzed. Before phosphorylation, rat cell myosin yielded a 2D 
pattern of MLC similar to that of Fig. 4 A. Upon phosphory- 
lation by either kinase, some mass of spot a  shifted to spot 
b,  and at the same time,  spot b  was radiolabeled with 32p. 
This suggests that monophosphorylated MLC migrates at the 
same position on our 2D gel system despite the fact that these 
two kinases phosphorylate different sites.  Second, the iso- 
electric point of spot a  did not change after treatment with 
phosphatase,  suggesting that spot a  represents an unphos- 
phorylated form of MLC (data not shown). 
Next,  we have analyzed the 2D  patterns  of 35S-labeled 
MLC in mitotically arrested cells (Fig. 4 C) and in cells at 
30 rain after the release of mitotic arrest (Fig. 4 E). We have 
found that the level of phosphorylated forms of MLC in mi- 
totically arrested cells is higher than that in nonmitotic cells, 
and that the level of phosphorylation becomes even higher 
in cells after the release of mitotic arrest than in mitotically 
arrested cells. As Fig. 4, C and E show, the amount of spot 
b is increased both in mitotically arrested cells and cells at 
30 rain, and spot c becomes recognizable in cells at 30 min. 
The 2D gel patterns (Fig. 4, D and F) of 32p-labeled MLCs 
have confirmed that spots b and c are heavily labeled with 
32p. It also  shows  that a  multiply phosphorylated form of 
MLC (spot d) appears in cells 30 rain after the release of mi- 
totic arrest (Fig. 4 F). 
We have determined the molar ratio of the phosphorylated 
forms (spots b and c) to total MLC (spots a, b, and c) using 
a Phosphorlrnager. We did not quantitate intensities of  minor 
spots just below the spots a  and b as the intensities of these 
spots are very low in comparison with the major spots a, b, 
and c (these minor spots are likely to be a minor isoform of 
MLC). The ratios are 0.16 ±  0.06 in nonmitotic cells, 0.31 
±  0.05 in mitotically arrested cells, and 0.49 +  0.05 in cells 
30 min after the release of mitotic arrest. 
In Vitro Phosphorylation of  MLC by Mitotic and 
Nonmitotic Extracts 
The in vivo phosphorylation of MLC suggests that there are 
mitosis-specific kinase activities which phosphorylate MLC 
at Ser-1/2. We have thus examined whether cell extracts show 
MLC kinase activities in a mitosis-specific way. 
We have first fractionated mitotic and nonmitotic HeLa 
cell extracts by gel filtration on a Sephacryl S-300 column, 
and kinase activities have been examined using both histone 
H1 and MLC as substrates.  As Fig. 5  shows,  MLC kinase 
activities of both mitotic and nonmitotic extracts are eluted 
as three peaks from the column although the activity of each 
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Figure 5. Fractionation of MLC kinase activities in mitotic and nonmitotic extracts by Sephacryl S-300 gel filtration.  Mitotic and nonmitotic 
HeLa cell extracts  were loaded on Sephacryl S-300 column, and each fraction was tested  for its activity to phosphorylate histone H1 and 
MLC. A and C are the elution profiles of mitotic and nonmitotic cell extracts,  respectively;  B and D show Histone HI and MLC kinase 
activities  of mitotic and nonmitotic eluents,  respectively. Histone H1 kinase activity of mitotic cell extracts  is eluted as a large single peak 
while nonmitotic cell  extracts  show a very low activity  of histone H1 kinase  activity.  Both mitotic and nonmitotic cell extracts  appear 
to have three peaks of MLC kinase  activity. 
peak is higher in mitotic extracts than in nonmitotic extracts 
(Fig.  5, B  and D).  Analyses of phosphorylation sites  (Fig. 
6) have revealed that only the middle peak activity of mitotic 
eluents phosphorylates MLC at Ser-1/2 (Fig. 6, lane 2) while 
all other activities including the three peak activities of non- 
mitotic eluents phosphorylate MLC at the MLCK sites. It is 
worthy of note that phosphorylation by the middle peak of 
mitotic eluents is similar to that observed in vivo in mitotic 
cells;  the  phosphorylation  sites  are  at  Ser-1/2  but  not  at 
Thr-9. 
The  middle  peak  of MLC  kinase  activity  from  mitotic 
eluents appears to correspond to the peak of histone HI ki- 
nase  activity  of mitotic  extracts  (Fig.  5  B).  To  examine 
whether cdc2 kinase phosphorylates MLC at the C-kinase 
sites as reported (31), cdc2 kinase was purified from the mid- 
dle peak of the S-300 fractions by pl 3 affinity column chro- 
matography. Two methods were used for the specific elution 
of cdc2  kinase  from a  p13  column.  One was  to elute  the 
column with p13 protein (5) and the other was to elute with 
a solution containing both 0.5M NaC1 and 50 % ethylene gly- 
col (21). Either elution method yielded essentially the same 
results, and we will describe the results obtained with the lat- 
ter  method. 
Figure  6.  Analyses of phos- 
phorylation  sites  of  MLC 
phosphorylated  with  sepha- 
cryl S-300 fractions of mitotic 
and  nonmitotic  eluents  (see 
Fig. 5). The peak fractions of 
MLC kinase activity from mi- 
totic  and  nonmitotic  eluents 
were  used  to  phosphorylate 
MLC, and the sites were ana- 
lyzed  by  peptide  mapping. 
Only the  middle  peak (frac- 
tion  M60)  of  the  mitotic 
eluent  contains  an  activity 
which  phosphorylates  MLC 
at Ser-l/2 while  all the other 
peak  activities  mainly  phos- 
phorylate  MLC  at  Ser-19. 
Note that fraction M60 does 
not  phosphorylate  Thr-9. 
Lanes 1-3 and lanes  4-6 are 
from mitotic  and  nonmitotic 
eluents,  respectively.  Lane 1, fraction 51; lane 2, fraction 60; lane 
3, fraction 69; lane 4, fraction 48; lane 5, fraction 60; lane 6, frac- 
tion 69. 
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Figure  7.  p13  Sepharose 
affinity column chromatogra- 
phy  of the  Sephacryl  S-300 
fractions  of  mitosis-specific 
MLC kinase activity. (A) The 
middle  peak  activity  of mi- 
totic eluent was loaded on a 
p13 Sepharose column to pu- 
rify cdc2 kinase. The column 
was washed first with solution 
A containing 0.5 M NaCI (ar- 
row with W/), second with the 
same solution containing 50 % 
ethylene glycol (indicated by 
W2), and then eluted with so- 
lution  A  containing  both 
0.5 M NaCI and 50% ethylene 
glycol (E).  Both histone  H1 
and  MLC  kinase  activities 
were measured (B). Analyses 
of  phosphorylation  sites of 
MLC.  MLC  was  phos- 
phorylated by the fractions of 
pl 3 beads column chromatog- 
raphy. Lane 1, fraction 3; lane 
2, fraction 7; lane 3, fraction 
t 13; lane 4, fraction 18; lane 
5, fraction 24. 
As Fig. 7 A shows, cdc2 kinase bound to the column is 
eluted by solution A containing both 0.5 M NaC1 and 50% 
ethylene glycol. As expected, the eluted cdc2 kinase shows 
a very high histone H1 kinase activity. The kinase is also able 
to phosphorylate MLC  when MLC isolated from myosin 
heavy chain was used as a substrate. Phosphopeptide analy- 
ses (Fig. 7 B) have revealed that the sites of phosphorylation 
are Ser-1/2, confirming the results reported by Satterwhite et 
al. (31). It should be noted that the phosphorylation at Thr-9 
becomes much more noticeable with cdc2 kinase than that 
observed with the kinase of the S-300 fractions (compare 
Fig.  7 B, lane 5  with Fig.  6, lane 2). 
MLC is a poor substrate for purified cdc2 kinase when it 
is compared with other substrates including histone H1 and 
chick smooth muscle caldesmon. As the time course experi- 
ment of Fig.  8 shows, purified cdc2 kinase exhibits a very 
slow rate of MLC phosphorylation when MLC isolated from 
heavy chain of smooth muscle myosin 1I is used as a  sub- 
strate. On the contrary, both histone H1 and chick smooth 
muscle caldesmon quickly incorporate phosphate under the 
same conditions. 
Heavy chain-associated MLC from chick smooth muscle 
is an even poorer substrate for cdc2 kinase as virtually no 
phosphorylation of MLC is  detected in 2  h  of incubation 
(Fig. 8). This situation is slightly improved when nonmuscle 
myosin II purified from bovine adrenal medulla is used in- 
stead of smooth muscle myosin II. Phosphate incorporation 
is increased from 0 to 0.015 mol per mol protein after 2 h 
of incubation with purified cdc2 kinase. 
Stoichiometry of MLC phosphorylation by cdc2 kinase is 
very low. A value of 0.076 mol phosphate per mol of MLC 
is calculated at 2 hr incubation with cdc2 kinase (Table I). 
On the other hand, cdc2 kinase phosphorylates chick smooth 
muscle caldesmon at a ratio of 2 mol per mol of protein un- 
der the same conditions, the value of which is consistent with 
the previous report by Mak et al.,  (16).  MLCK and PKC 
phosphorylate MLC at a ratio of 0.73 and 1.78, respectively. 
Discussion 
This paper has  shown that the in vivo phosphorylation of 
MLC is drastically changed during mitosis. We have found 
that (a) the basic level of MLC phosphorylation is very low 
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Figure 8. Time course of phosphorylation  of MLC, caldesmon and 
histone H1 by purified cdc2 kinase. MLC isolated from chick giz- 
hard myosin was used for time course experiments. For compari- 
son, chick smooth muscle caldesmon, and histone H1 were also 
phosphorylated by the same preparation of cdc2 kinase under the 
same  conditions.  (t3), phosphorylation  of isolated  MLC;  (I), 
phosphorylation of heavy chain-associated MLC; (o), phosphory- 
lation of histone HI; (e), phosphorylation of chick smooth muscle 
caldesmon. Phosphate incorporation was determined by counting 
radioactivities of excised gel bands of MLC. 
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Muscle MIC by cdc2 Kinase, MLCK, and Protein Kinase 
C (mol phosphate/mol protein)* 
cdc2  kinase  MLCK  PKC 
Isolated MLC  0.076  0.73  1.78 
Heavy chain- 
associated MLC  0  0.94  0.42 
Chick smooth 
muscle caidesmon  2.0  ND  ND 
* The stoichiometry is determined at 2 h of incubation. 
ND, not determined. 
in nonmitotic cells; (b)  the extent of phosphorylation be- 
comes higher during mitosis; (c)  MLC in mitotically ar- 
rested cells is mainly phosphorylated at Ser-1/2; (d) the total 
level of phosphorylation is further increased at 30 min after 
the release of mitotic arrest when some cells start cytokine- 
sis; and (e) during this process, the sites of phosphorylation 
are switched from Set-l/2 to Ser-19. 
Quantitation of the phosphorylation state of MLC has re- 
vealed that the molar ratio of the phosphorylated forms to 
total MLC is 0.16  +  0.06 in nonmitotic cells, 0.31  5:0.05 
in mitotically arrested cells, and 0.49:1:0.05 in cells 30 min 
after the release of mitotic arrest.  When these values are 
compared with the incorporation of 3~p-radioactivities dur- 
ing mitosis (Fig. 2), the following trends may be noted. First, 
the rate of  phosphate turnover is likely to be very slow during 
interphase.  The  extent  of 32p-phosphate  incorporation  in 
nonmitotic cells is much too low when the values of phos- 
phate incorporation are compared with the stoichiometry 
(the molar ratio) of phosphorylation between mitotic and 
nonmitotic cells. Second, ~15% of MLC (the difference in 
the molar ratio between mitotic and nonmitotic ceils) ap- 
pears to become phosphorylated at Set-l/2. Third, this I5 % 
of MLC seems to be quickly dephosphorylated and instead, 
'~33 % of MLC appears to be phosphorylated mainly at Ser- 
19 after the release of  mitotic arrest. Fourth, dephosphoryla- 
tion of MLC after cytokinesis occurs slowly, suggesting that 
phosphorylation of MLC at the MLCK sites may be required 
for cell spreading after cell division (Fig. 2). 
These notions further suggest that the phosphorylation of 
one third of myosin II would be sufficient to complete cell 
division. The low stoichiometry of phosphorylation during 
cell division may be related to the report that, in smooth 
muscle, phosphorylation of only 5 or 20%  of myosin (de- 
pending on the sources of smooth muscle) is sufficient for 
tension development (6,  12).  It remains to be investigated 
whether the phosphorylated myosin is specifically localized 
in the cleavage  furrow or uniformly distributed throughout 
the cytoplasm of dividing cells. 
The switching of sites of phosphorylation from Set-l/2 to 
Set-19 is likely to be a signal for the induction of  cytokinesis, 
since it is well established that phosphorylation at Ser-19, the 
MLCK site,  induces contraction of actomyosin in smooth 
muscle and nonmuscle cells (for reviews see 33, 36). Which 
kinase phosphorylates MLC at the MLCK sites? A natural 
candidate is MLCK. Inhibitors of MLCK were reported to 
block cytokinesis (26).  More recently, antisense expression 
of MLCK has been reported to inhibit cell proliferation of 
fibroblasts (35).  Fishkind et al., however,  presented an in- 
teresting result suggesting a function for MLCK during mi- 
tosis (10). They have microinjected unregulated, constitu- 
tively active catalytic fragments of MLCK into mitotic cells, 
and found two effects. First, there is a significant delay in the 
transit time from nuclear envelope breakdown to anaphase 
onset. Second, the microinjection induces motile surface ac- 
tivity during and after metaphase. However, the microinjec- 
tion neither affects the formation of cleavage  furrows nor 
changes  the  rate  of  contraction  of  cleavage  furrows.  If 
MLCK  regulates  contraction  of  cleavage  furrows,  then 
microinjection of unregulated MLCK would affect the ki- 
netics of cytokinesis and the formation of cleavage furrow. 
It is thus an open question, at present, whether MLCK or 
other kinases are involved in the regulation of cytokinesis. 
For example, calcium/calmodulin-dependent kinase and pro- 
tease-activated protein  kinase could also be  a  candidate, 
since they were reported to phosphorylate MLC at the MLCK 
sites (7,  31, 37). 
Satterwhite et al., (31) have proposed that the phosphory- 
lation at the C-kinase sites during prometaphase keeps myo- 
sin II from being activated prematurely. This idea is not only 
very attractive but also possible because phosphorylation of 
MLC by protein kinase C is known to inhibit both actomyo- 
sin ATPase and myosin filament assembly (2, 28). It should 
be noted, however that only 15 % of myosin appears to be 
phosphorylated at Ser-1/2 during mitosis. It is possible that 
such a low fraction of phosphorylated myosin cooperatively 
inhibits the rest of myosin. Alternatively, the phosphorylated 
myosin may be specifically localized in the cleavage furrow, 
thereby keeping the myosin in the cleavage furrow from ac- 
tivating. Another point to be noted is that the sites of phos- 
phorylation during mitosis are not exactly the same as the 
sites used by protein kinase C. Phosphopeptide analyses have 
revealed that phosphorylation at Thr-9,  one of the major 
phosphorylation sites by protein kinase C, is not observed in 
vivo. In addition, the peptide patterns made by the phosphor- 
ylation at Ser-1/2 during mitosis are considerably different 
from the in vitro phosphorylation by protein kinase C. It is 
thus very important to elucidate whether the mitotic phos- 
phorylation at Ser-1/2 has effects on actomyosin contractility 
similar to those observed after phosphorylation with protein 
kinase C. If the mitotic phosphorylation indeed has similar 
inhibitory effects on myosin assembly, it may also play a role 
in the disassembly of stress fibers during prophase, which 
leads to rounding of cell shape. 
Which kinase is responsible for the mitosis specific phos- 
phorylation of MLC at Ser-1/2? Protein kinase C may not be 
involved in this mitotic phosphorylation because the phos- 
phopeptide map was considerably different from that of in 
vivo phosphorylation. We have confirmed the results by Sat- 
terwhite et al., (31) that purified cdc2 kinase is able to phos- 
phorylate MLC in vitro at Ser-1/2. There remain, however, 
several  questions to be answered before it would be con- 
ctuded that cdc2 is involved. First, the activity is quite low, 
particularly when heavy chain-associated MLC is used as a 
substrate.  Second, the phosphorylation is not stoichiometric. 
Third,  the peptide map of in vivo phosphorylation differs 
from that of in vitro phosphorylation by cdc2 kinase. While 
the in vivo phosphorylation at Thr-9 is not observed, cdc2 
kinase phosphorylates Thr-9  in  addition to  Ser-1 and/or 
Ser-2. 
These problems could be explained in several ways. For 
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MLC with cdc2 kinase may not be appropriate. Additional 
factors  may  be  required  for  effective  phosphorylation  of 
MLC  with cdc2 kinase.  Further, contaminating  phospha- 
tases could explain  the difference  in the peptide  maps be- 
tween in vivo and in vitro phosphorylation;  the phosphoryla- 
tion at Thr-9 may be specifically  unphosphorylated  during 
immunoprecipitation  in spite of the presence of the phospha- 
tase inhibitor.  Indeed,  dephosphorylation  at Thr-9 was re- 
ported to occur more easily (9). Nevertheless,  it is equally 
possible that kinases other than cdc2 kinase are responsible 
for the phosphorylation of MLC at Ser-1/2. This possibility 
may be supported by the fact that the crude kinase from the 
S-300  fraction  phosphorylates  MLC  at  Thr-9  to a  much 
lesser extent than does purified cdc2 kinase.  However, this 
could be again  explained  by contaminating  phosphatases, 
which may be removed during purification with pl 3 affinity 
chromatography.  Apparently  more  studies  are  needed  to 
solve these problems. 
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